≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Benign neoplasm: Parathyroid gland

Endpoint Browser

CD2_BENIGN_PARATHYROID_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D35.1&
  • Hospital discharge: ICD-9 — 2271
  • Cause of death: ICD-10 — D35.1&
  • Cause of death: ICD-9 — 2271

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D35
Name in latin
Neoplasma benignum glandulae parathyreoideae

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 365 259 106
Unadjusted period prevalence (%) 0.08 0.09 0.05
Median age at first event (years) 60.83 60.15 62.51

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
330
Matched controls
3298
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D35.1
ICD-10 Finland
Benign neoplasm: Parathyroid gland
4503599627370496.0
323.0
301
*
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
257.3
182.3
173
14
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
106.7
137.7
145
24
E21.0
ICD-10 Finland
Primary hyperparathyroidism
79.1
90.5
100
18
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
116.6
75.9
80
9
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.3
44.3
205
776
BBA20
NOMESCO Finland
Exploration of parathyroid gland
252.9
44.1
44
*
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
82.8
33.6
37
5
E21.2
ICD-10 Finland
Other hyperparathyroidism
97.6
32.4
35
*
E83.50
ICD-10 Finland
Hypercalcemia
35.8
32.1
41
13
2271A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Parathyroid gland
+∞
27.5
26
*
115
Kela drug reimbursment
Breast cancer
+∞
26.4
25
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.9
25.4
134
495
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
24.3
23
*
2522
FHL
Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)
246.4
22.9
23
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
9.5
22.9
48
58
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
12.8
22.4
40
35
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
21.1
20
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
21.1
20
*
A11CC03
ATC
alfacalcidol; systemic
18.5
20.9
32
19
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
6.8
19.9
52
88
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
18.9
18
*
PJA12
NOMESCO Finland
Sentinel node biopsy
200.9
18.7
19
*
H05BX01
ATC
cinacalcet; oral
46.9
18.5
22
5
321
Kela drug reimbursment
Paricalcitol and cinacalcet
39.1
17.8
22
6
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
19.8
16.3
24
13
A04AA02
ATC
granisetron; systemic, transdermal
+∞
15.7
15
*
E21
ICD-10 Finland
Hyperparathyroidism and other disorders of parathyroid gland
59.5
14.9
17
*
N20.0
ICD-10 Finland
Calculus of kidney
15.1
14.8
24
17
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
83.9
14.7
16
*
130
Kela drug reimbursment
Malignant tumour
+∞
14.7
14
*
L02BA01
ATC
tamoxifen; oral
156.6
14.6
15
*
WZC30
NOMESCO Finland
Teaching
4.4
14.2
53
136
HAB40
NOMESCO Finland
Wedge excision of mammary gland
31.6
14.0
18
6
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
13.6
13
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
13.6
13
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
13.6
13
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.1
13.5
85
332
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
13.0
12.8
22
18
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
12.6
12
*
H02AB02
ATC
dexamethasone; systemic
13.1
12.3
21
17
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
14.1
12.1
20
15
KAT00
NOMESCO Finland
Extracorporeal shock wave lithotripsy of pelvis of kidney
31.3
11.7
15
5
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
67.4
11.7
13
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
11.5
11
*
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
36.4
11.4
14
*
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
13.4
11.3
19
15
L02BG04
ATC
letrozole; oral
20.9
11.2
16
8
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
26.1
11.2
15
6
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
9.7
11.2
22
24
N20.9
ICD-10 Finland
Urinary calculus, unspecified
8.2
10.6
23
30
2520A
ICD-9 Finland
Disorders of parathyroid gland, Hyperparathyroidism
113.5
10.5
11
*
HAC20
NOMESCO Finland
Total mastectomy
113.5
10.5
11
*
A12AA04
ATC
calcium carbonate; oral
16.7
10.5
16
10
KA1AE
NOMESCO Finland
Kidney ultrasound examination
11.9
9.7
17
15
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.4
9.5
28
56
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
9.1
9.4
19
22
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
9.4
9
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
116
Kela drug reimbursment
Prostate cancer
+∞
9.4
9
*
106
Kela drug reimbursment
Hypoparathyroidism
37.8
9.1
11
*
M04AA01
ATC
allopurinol; systemic
3.0
8.7
53
199
E23.00
ICD-10 Finland
Panhypopituitarism
51.4
8.7
10
*
N18.8
ICD-10 Finland
Other chronic renal failure
7.7
8.6
19
26
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.4
8.4
30
74
JN4BD
NOMESCO Finland
Extensive body CT
4.2
8.3
31
80
KH1AD
NOMESCO Finland
CT of urinary organs
6.2
8.1
21
36
I10
ICD-10 Finland
Essential (primary) hypertension
2.0
7.9
218
1637
E83.51
ICD-10 Finland
Hypocalcemia
46.1
7.7
9
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
18.9
7.6
11
6
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
18.9
7.6
11
6
A03FA01
ATC
metoclopramide; systemic, rectal
2.6
7.6
59
257
N20.1
ICD-10 Finland
Calculus of ureter
5.5
7.5
21
40
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
5.0
7.5
23
49
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
81.9
7.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
7.3
7
*
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
30.7
7.2
9
*
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
9.1
7.1
14
16
CA1TM
NOMESCO Finland
Calculation of intraocular lens power
6.6
7.0
17
27
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
5.0
7.0
21
44
WW500
NOMESCO Finland
Blood transfusion
8.5
6.9
14
17
E21.5
ICD-10 Finland
Disorder of parathyroid gland, unspecified
40.9
6.8
8
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
6.7
49
207
V03AE02
ATC
sevelamer; oral
23.1
6.7
9
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.6
6.6
48
202
UKC02
NOMESCO Finland
Cystoscopy
2.5
6.5
51
225
HA1AA
NOMESCO Finland
X-ray mammography
4.4
6.4
22
53
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
14.7
6.4
10
7
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.6
6.4
27
79
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
4.5
6.4
21
49
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
D44.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Parathyroid gland
+∞
6.3
6
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
6.3
6
*
B05DB
ATC
Hypertonic solutions
27.2
6.3
8
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
6.2
142
968
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
7.9
6.2
13
17
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
6.2
117
751
P01AB01
ATC
metronidazole; oral, rectal
1.8
6.1
138
936
N02BE01
ATC
paracetamol; systemic, rectal
2.2
6.1
288
2500
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
6.1
58
283

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
184
241
14.38
146.61
7.0
3.6
119.2
80.3
ng/l
2.77
168
215
155
338
7.23
74.45
10.7
4.4
1.0
1.0
mmol/l
2.65
144
306
300
1457
6.95
53.24
19.5
5.2
1.3
1.2
mmol/l
14.22
277
1262
122
297
5.67
49.99
16.3
3.6
—
—
—
0
0
261
1300
4.54
39.96
4.2
2.3
78.9
80.2
nmol/l
0.34
247
1138
212
961
3.88
36.00
4.1
2.1
2.4
2.4
mmol/l
7.57
195
791
83
208
4.87
31.75
1.3
1.1
—
—
—
0
0
152
619
3.49
29.11
3.0
1.9
—
—
—
0
0
178
803
3.37
28.80
2.9
2.0
—
—
—
0
0
199
967
3.33
28.32
2.3
1.7
—
—
—
0
0
228
1252
3.19
25.42
5.1
3.5
—
—
—
0
0
224
1252
3.04
23.57
8.7
3.4
36.0
35.8
g/l
0.30
213
1153
44
82
5.96
23.21
1.3
1.3
—
—
—
0
0
135
577
3.13
22.94
3.2
2.1
2.5
2.4
mmol/l
6.16
125
492
33
53
6.75
20.09
5.0
2.3
—
—
—
0
0
36
69
5.68
18.36
4.3
2.8
24.6
25.0
mmol/l
0.17
24
61
246
1577
2.72
17.85
8.4
6.1
4.1
4.2
e9/l
0.28
217
1361
28
44
6.81
17.36
3.5
3.0
—
—
—
0
0
216
1337
2.51
16.27
11.5
4.7
1.3
1.2
mmol/l
10.42
205
1190
56
169
3.73
16.22
4.6
3.6
5.2
5.2
kpa
0.02
49
158
96
408
2.84
15.73
18.8
23.4
1.4
1.2
inr
0.79
61
55
309
2304
3.22
15.51
11.1
5.2
85.7
74.9
u/l
0.99
296
2096
54
164
3.69
15.47
4.2
3.6
7.4
7.4
ph
—
5
22
121
602
2.51
14.30
5.6
2.4
3.7
7.1
e6/l
1.72
112
529
152
858
2.32
13.36
8.8
3.0
7.4
7.4
ph
1.79
25
139
118
600
2.43
13.14
4.2
4.0
113.9
283.3
ng/l
0.86
85
480
205
1329
2.24
12.70
5.4
5.4
3.2
2.9
%
0.83
194
1220
17
22
8.06
12.38
1.3
1.4
—
—
—
0
0
148
856
2.23
11.99
5.8
3.1
95.2
119.5
e6/l
0.09
129
643
197
1277
2.18
11.96
5.5
5.4
0.7
0.7
%
0.56
187
1174
203
1332
2.18
11.94
5.7
5.7
8.9
8.5
%
0.92
193
1232
204
1354
2.15
11.50
5.6
5.6
27.0
27.9
%
0.53
194
1243
164
1016
2.12
10.91
5.9
3.6
70.5
101.2
e6/l
0.56
131
706
217
1498
2.11
10.75
5.6
5.4
0.2
0.2
e9/l
0.36
186
1308
123
697
2.15
10.18
4.5
3.8
—
—
—
0
0
209
1446
2.04
10.02
5.5
5.2
0.0
0.0
e9/l
0.62
179
1236
241
1760
2.09
9.90
7.3
3.9
6.5
6.8
mmol/l
1.99
234
1633
37
119
3.35
9.64
3.8
3.5
—
—
—
0
0
45
163
3.01
9.63
3.7
1.3
6.4
4.4
ug/l
0.35
39
128
197
1350
2.00
9.53
5.5
5.3
57.9
57.5
%
0.21
187
1247
20
41
5.10
9.42
1.5
1.2
—
—
nmol/l
—
0
0
21
45
4.89
9.42
1.5
1.2
—
—
—
0
0
154
975
2.00
9.28
4.9
3.1
—
—
—
0
0
52
210
2.72
9.12
9.9
5.8
—
—
—
0
0
132
797
2.03
9.04
5.3
2.3
3977.0
7013.0
umol/l
0.34
123
677
152
965
1.99
9.03
3.9
3.9
—
—
—
0
0
273
2123
2.13
9.03
7.0
4.2
—
—
—
0
0
207
1461
1.96
9.01
5.5
5.2
1.7
1.9
e9/l
1.76
175
1278
208
1471
1.96
8.99
6.6
3.5
12.1
11.4
umol/l
0.25
200
1370
109
621
2.08
8.70
2.0
1.8
967.1
1227.1
nmol/l
2.68
92
468
202
1434
1.92
8.43
5.4
5.2
0.6
0.6
e9/l
0.21
172
1223
62
289
2.38
8.05
13.4
3.2
—
—
—
0
0
60
277
2.40
7.96
13.6
3.2
2.1
2.6
mmol/l
0.51
50
224
13
21
6.38
7.76
1.2
1.1
—
—
—
0
0
111
661
1.98
7.71
1.7
1.6
1.0
1.0
mg/l
0.13
90
505
27
82
3.48
7.68
2.1
1.7
—
—
—
0
0
55
248
2.43
7.67
7.7
2.7
67.8
69.8
e9/l
0.22
47
195
60
282
2.35
7.64
3.3
3.5
241.5
222.9
ng/l
0.10
55
262
286
2330
2.05
7.40
7.0
4.3
15.1
12.3
mm/h
2.16
274
2128
121
751
1.91
7.39
3.7
2.1
2.5
3.1
mg/l
3.15
110
636
52
238
2.38
7.01
2.1
1.4
67.6
67.5
g/l
0.03
42
211
143
951
1.83
6.95
4.4
2.1
63.8
58.6
u/l
0.32
135
860
186
1352
1.77
6.60
2.3
2.0
102.3
97.3
pmol/l
0.52
107
643
46
209
2.37
6.30
2.1
1.4
—
—
—
0
0
31
117
2.80
6.17
1.2
1.2
—
—
—
0
0
107
680
1.81
5.87
1.4
1.3
—
—
—
0
0
92
563
1.85
5.69
1.3
1.3
2.2
2.6
g/l
1.06
59
325
18
51
3.66
5.68
1.2
1.3
—
—
—
0
0
150
1059
1.71
5.67
5.1
3.2
7.3
7.1
mmol/l
0.18
135
880
71
404
1.94
5.47
1.5
1.3
728.0
517.1
titre
0.27
15
110
288
2458
1.81
5.11
5.2
3.9
14.3
14.9
pmol/l
3.12
271
2228
96
614
1.76
5.07
3.8
3.9
—
—
—
0
0
26
100
2.72
5.01
4.3
2.1
0.3
0.2
g/l
0.62
16
24
327
2922
2.14
4.87
6.3
4.8
1.8
1.9
mu/l
0.73
308
2658
18
57
3.27
4.83
2.1
1.3
—
—
—
0
0
289
3183
0.56
4.57
19.0
12.1
—
—
—
0
0
11
26
4.33
4.38
1.0
1.1
—
—
—
0
0
167
1276
1.57
4.27
5.0
2.7
148.1
115.9
ug/l
1.12
160
1170
333
3029
2.13
4.19
24.6
12.1
26.2
21.7
mg/l
1.69
288
2322
135
1000
1.56
3.87
2.3
2.1
241.9
180.0
u/l
0.26
124
931
14
44
3.27
3.81
1.3
1.3
296.2
380.3
pmol/l
—
9
34
110
785
1.57
3.69
4.9
3.0
0.1
0.5
e6/l
4.41
78
577
137
1030
1.53
3.63
5.3
3.2
61.6
174.3
mg/l
0.65
106
624
36
190
1.99
3.43
1.1
1.4
—
35.0
—
0
11
12
37
3.32
3.37
2.9
1.2
—
—
—
0
0
13
44
3.03
3.17
1.2
1.1
—
—
—
0
0
82
566
1.58
3.13
1.3
1.3
9.1
12.4
u/ml
0.17
32
207
139
1085
1.45
2.93
6.0
4.1
12.3
7.0
mg/mmol
1.02
102
655
8
17
4.79
2.93
2.1
1.9
—
—
—
0
0
37
211
1.84
2.84
3.1
2.8
—
—
—
0
0
11
36
3.12
2.83
1.3
1.1
327.3
229.7
u/ml
—
6
21
79
555
1.54
2.77
3.6
2.7
505.2
527.1
mosm/kgh2o
0.52
70
466
5
6
8.43
2.75
2.2
1.2
—
—
—
0
0
36
206
1.83
2.73
2.9
4.1
0.0
0.1
%
0.80
14
38
37
216
1.79
2.64
3.0
4.0
0.8
0.7
%
0.09
15
41
122
948
1.43
2.58
5.6
5.5
—
—
—
0
0
82
591
1.50
2.55
1.3
1.3
60.4
39.9
iu/ml
0.30
20
190
51
330
1.63
2.53
2.8
1.6
—
—
—
0
0
79
1063
0.67
2.51
2.7
3.1
—
—
—
0
0
7
16
4.44
2.48
1.1
1.2
—
—
—
0
0
5
8
6.32
2.38
1.4
1.4
149.4
107.3
iu/ml
—
5
8
100
761
1.43
2.34
4.3
2.9
—
—
—
0
0
6
13
4.67
2.28
1.7
1.2
—
—
—
0
0
22
117
1.94
2.11
1.7
1.5
13.3
25.1
u/ml
0.80
22
112
343
3269
1.82
2.01
28.8
14.3
94.4
75.8
umol/l
4.12
343
3269
24
134
1.85
2.00
3.7
7.5
—
—
—
0
0
56
392
1.51
2.00
2.7
1.9
—
—
—
0
0
248
2709
0.74
1.95
19.7
13.6
39.9
39.8
%
0.09
169
1822
100
786
1.38
1.92
1.6
1.5
19.5
22.2
nmol/l
1.03
85
673
18
93
1.98
1.88
1.2
1.3
37.8
38.0
g/l
—
10
79
85
653
1.39
1.87
8.6
4.5
—
—
—
0
0
6
17
3.57
1.84
1.0
1.4
—
—
—
0
0
27
161
1.73
1.84
1.3
1.2
—
—
—
0
0
18
94
1.96
1.83
1.0
1.1
—
—
—
0
0
5
12
4.21
1.83
1.4
1.3
—
—
—
0
0
12
53
2.31
1.82
1.3
1.1
—
—
—
0
0
6
18
3.37
1.75
2.0
2.7
—
—
—
0
0
89
697
1.37
1.74
5.5
3.9
2.1
2.0
ug/l
0.02
79
620
6
19
3.19
1.67
1.3
1.1
—
—
—
0
0
7
25
2.83
1.65
1.0
1.2
—
—
—
0
0
12
58
2.11
1.51
6.2
3.2
—
—
—
0
0
34
229
1.53
1.48
3.8
4.7
1.0
1.3
mmol/l
2.66
34
220
9
38
2.40
1.46
1.1
1.3
—
—
—
0
0
14
73
1.95
1.46
3.6
2.4
2.1
1.6
mg/l
1.15
14
66
50
366
1.42
1.45
1.6
1.4
—
—
—
0
0
6
22
2.76
1.44
3.0
1.6
11.8
10.6
%
—
6
22
44
316
1.45
1.42
1.3
1.3
—
—
—
0
0
11
53
2.11
1.40
1.2
1.6
—
—
—
0
0
19
113
1.72
1.34
1.1
1.2
—
1.3
—
0
8
82
660
1.31
1.33
1.2
1.2
0.8
2.4
u/ml
1.21
17
180
14
76
1.88
1.31
1.8
1.6
17440.6
16256.0
e6/l
—
9
54
13
69
1.92
1.30
1.2
1.2
—
—
—
0
0
5
18
2.80
1.29
1.0
1.1
—
—
—
0
0
5
18
2.80
1.29
1.0
1.6
—
—
—
0
0
8
35
2.31
1.27
1.0
1.1
—
—
—
0
0
38
272
1.44
1.26
2.1
1.4
—
—
—
0
0
6
25
2.42
1.25
1.3
1.6
—
—
—
0
0
340
3286
1.51
1.17
14.6
9.1
24.9
24.7
u/l
0.08
332
3142
43
320
1.39
1.16
3.3
5.7
5.3
5.2
kpa
0.47
43
310
43
320
1.39
1.16
3.3
5.7
12.6
11.4
kpa
0.95
43
309
331
3188
1.41
1.11
5.4
5.4
2.8
2.8
mmol/l
0.01
314
2916
5
21
2.40
1.09
3.0
2.5
—
—
—
0
0
138
1212
1.22
1.07
13.6
9.4
1.3
1.3
inr
0.10
36
345
325
3126
1.36
1.05
4.9
4.8
4.7
4.7
mmol/l
0.01
312
2863
11
60
1.86
1.04
1.5
1.5
—
—
—
0
0
5
22
2.29
1.03
1.0
1.1
—
—
—
0
0
38
284
1.38
1.02
3.4
5.9
96.6
95.2
%
1.98
38
275
322
3096
1.34
1.02
4.9
4.7
1.5
1.5
mmol/l
1.77
307
2832
7
35
2.02
1.00
1.9
1.1
—
—
—
0
0
9
49
1.86
0.99
1.3
1.2
—
—
—
0
0
13
77
1.71
0.96
1.5
1.3
312.6
304.7
ug/g
—
7
45
11
62
1.80
0.95
1.7
1.4
306.8
62.8
pmol/l
0.94
11
62
310
2972
1.29
0.94
7.6
6.2
40.1
40.4
mmol/mol
0.17
291
2755
48
378
1.31
0.93
3.1
2.6
0.8
0.8
ug/l
0.01
34
250
41
316
1.34
0.92
3.3
5.8
0.8
1.7
mmol/l
1.08
30
250
8
45
1.79
0.84
1.3
1.6
—
—
—
0
0
6
31
1.95
0.84
2.5
2.4
—
—
—
0
0
55
448
1.27
0.84
1.2
1.2
—
—
—
0
0
31
233
1.36
0.82
2.2
1.4
—
—
—
0
0
6
32
1.89
0.82
1.2
1.3
—
—
—
0
0
0
28
0.00
0.76
0.0
2.4
—
—
—
0
0
321
3110
1.27
0.74
5.5
4.8
6.0
6.0
mmol/l
0.21
303
2806
23
168
1.39
0.73
2.4
2.4
—
—
—
0
0
5
26
1.94
0.71
1.0
1.1
—
—
—
0
0
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
5
28
1.80
0.66
2.8
1.6
—
—
—
0
0
132
1199
1.16
0.66
4.1
3.5
—
—
—
0
0
43
355
1.24
0.61
1.8
2.1
79.7
118.8
ug/g
1.05
35
281
0
20
0.00
0.60
0.0
2.3
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
21
159
1.34
0.56
2.2
1.5
—
—
—
0
0
308
2993
1.19
0.54
4.6
4.2
1.4
1.3
mmol/l
2.44
289
2708
6
39
1.55
0.53
1.8
3.2
—
—
—
0
0
6
40
1.51
0.52
1.0
1.1
—
—
—
0
0
74
828
0.87
0.49
5.8
3.8
0.0
0.0
estimate
0.00
25
252
19
146
1.32
0.48
1.2
1.3
—
—
—
0
0
10
68
1.48
0.47
1.4
1.1
—
64.0
—
0
5
80
719
1.14
0.46
1.9
1.7
633.5
453.3
pmol/l
0.43
72
587
39
330
1.20
0.46
2.5
1.7
—
—
—
0
0
11
77
1.44
0.46
2.5
3.3
—
—
—
0
0
16
122
1.33
0.43
1.1
1.1
—
—
—
0
0
8
56
1.44
0.43
2.0
1.9
34.1
30.7
umol/l
—
8
47
8
56
1.44
0.43
1.1
1.2
—
—
—
0
0
25
204
1.24
0.42
3.1
4.1
0.0
0.0
%
—
6
36
117
1258
0.90
0.41
3.9
3.6
45.1
64.2
ng/l
0.25
86
883
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
1.4
—
0
14
9
67
1.35
0.38
2.6
2.5
—
—
—
0
0
65
715
0.89
0.34
5.9
4.0
1.0
1.0
kg/l
0.01
22
105
161
1531
1.09
0.34
4.7
3.7
0.0
0.0
estimate
0.00
26
263
28
238
1.19
0.33
1.1
1.2
—
—
—
0
0
81
877
0.90
0.33
1.6
1.7
1.5
1.4
mmol/l
1.10
72
735
7
53
1.33
0.31
1.4
1.4
85.0
70.3
mmol/l
—
7
45
18
217
0.82
0.30
1.3
1.3
—
—
—
0
0
14
171
0.81
0.26
3.4
3.8
—
—
—
0
0
30
339
0.87
0.25
1.6
1.6
—
—
—
0
0
215
2209
0.94
0.23
3.7
3.9
—
—
—
0
0
16
134
1.20
0.23
2.7
1.9
—
—
—
0
0
12
97
1.25
0.23
1.3
1.2
—
—
—
0
0
7
95
0.73
0.22
3.4
4.1
4.1
3.9
mmol/l
—
7
88
135
1295
1.07
0.22
10.9
8.3
0.0
0.0
e9/l
0.05
101
1055
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
15
126
1.20
0.21
1.6
1.7
—
—
—
0
0
161
1555
1.06
0.21
4.7
3.7
0.0
0.0
estimate
0.50
27
255
5
43
1.17
0.21
3.0
4.9
325.6
365.7
umol/l
—
5
37
28
250
1.13
0.20
1.3
1.4
—
—
—
0
0
6
50
1.20
0.20
3.2
1.8
70.0
61.8
%
—
6
50
17
195
0.87
0.18
1.3
1.3
—
—
—
0
0
13
110
1.19
0.17
1.3
1.6
—
—
—
0
0
158
1533
1.05
0.17
5.9
5.0
0.0
0.0
estimate
0.00
27
258
11
92
1.20
0.16
1.0
1.1
—
—
—
0
0
6
76
0.79
0.16
1.8
2.1
—
—
—
0
0
10
118
0.84
0.14
1.0
1.1
—
—
—
0
0
29
267
1.09
0.13
4.6
3.0
—
—
—
0
0
5
45
1.11
0.10
1.0
1.7
0.5
0.8
g/l
—
5
37
8
76
1.05
0.07
1.3
1.2
457.2
476.4
mg/l
—
8
69
27
256
1.06
0.06
1.6
1.4
—
—
—
0
0
22
233
0.94
0.06
8.3
3.5
—
—
—
0
0
14
129
1.09
0.05
3.1
4.1
—
—
—
0
0
24
231
1.04
0.03
1.1
1.4
—
—
—
0
0
84
830
1.02
0.02
4.5
3.3
—
—
—
0
0
73
728
1.00
0.00
4.1
3.6
—
—
—
0
0
12
117
1.03
0.00
17.5
8.6
—
—
—
0
0
12
115
1.04
0.00
2.5
3.6
1.2
1.4
mmol/l
0.44
12
110
20
196
1.02
0.00
2.5
4.7
—
—
—
0
0
0
8
0.00
0.00
0.0
13.4
—
1755.0
—
0
8
0
6
0.00
0.00
0.0
1.3
—
17.3
—
0
6
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
11.1
—
837.8
—
0
8
0
8
0.00
0.00
0.0
7.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
0.5
—
0
8
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
6
59
1.02
0.00
1.2
1.1
58.9
16.9
u/l
—
6
53
5
50
1.00
0.00
3.2
3.3
60.2
59.1
%
—
5
50
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
5
49
1.02
0.00
3.0
2.9
3.5
4.4
e9/l
—
5
49
5
54
0.92
0.00
2.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
9
90
1.00
0.00
3.8
5.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
7
75
0.93
0.00
7.7
3.2
7.4
7.4
ph
—
7
61
7
69
1.01
0.00
1.1
1.2
3.4
3.9
mmol/l
—
7
64
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_PARATHYROID_EXALLC – Benign neoplasm: Parathyroid gland

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).